These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10190267)

  • 1. Rett syndrome: randomized controlled trial of L-carnitine.
    Ellaway C; Williams K; Leonard H; Higgins G; Wilcken B; Christodoulou J
    J Child Neurol; 1999 Mar; 14(3):162-7. PubMed ID: 10190267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-term open label trial of L-carnitine in Rett syndrome.
    Ellaway CJ; Peat J; Williams K; Leonard H; Christodoulou J
    Brain Dev; 2001 Dec; 23 Suppl 1():S85-9. PubMed ID: 11738848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of creatine supplementation in Rett syndrome: a randomized, placebo-controlled trial.
    Freilinger M; Dunkler D; Lanator I; Item CB; Mühl A; Fowler B; Bodamer OA
    J Dev Behav Pediatr; 2011; 32(6):454-60. PubMed ID: 21654506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine as a treatment for Rett syndrome.
    Plioplys AV; Kasnicka I
    South Med J; 1993 Dec; 86(12):1411-2. PubMed ID: 8272924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.
    Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT
    J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients.
    Hagebeuk EE; Koelman JH; Duran M; Abeling NG; Vyth A; Poll-The BT
    J Child Neurol; 2011 Jun; 26(6):718-23. PubMed ID: 21427443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death?
    Guideri F; Acampa M; Hayek Y; Zappella M
    Pediatr Cardiol; 2005; 26(5):574-7. PubMed ID: 16235010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
    Glaze DG; Neul JL; Percy A; Feyma T; Beisang A; Yaroshinsky A; Stoms G; Zuchero D; Horrigan J; Glass L; Jones NE
    Pediatr Neurol; 2017 Nov; 76():37-46. PubMed ID: 28964591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical feature of Rett syndrome and MeCP2 genotype/phenotype correlation analysis].
    Bao XH; Pan H; Song FY; Wu XR
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):252-5. PubMed ID: 15157382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone.
    Percy AK; Glaze DG; Schultz RJ; Zoghbi HY; Williamson D; Frost JD; Jankovic JJ; del Junco D; Skender M; Waring S
    Ann Neurol; 1994 Apr; 35(4):464-70. PubMed ID: 8154874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized open-label trial of dextromethorphan in Rett syndrome.
    Smith-Hicks CL; Gupta S; Ewen JB; Hong M; Kratz L; Kelley R; Tierney E; Vaurio R; Bibat G; Sanyal A; Yenokyan G; Brereton N; Johnston MV; Naidu S
    Neurology; 2017 Oct; 89(16):1684-1690. PubMed ID: 28931647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Jones NE; Youakim JM
    Contemp Clin Trials; 2022 Mar; 114():106704. PubMed ID: 35149233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.
    Lenzi A; Sgrò P; Salacone P; Paoli D; Gilio B; Lombardo F; Santulli M; Agarwal A; Gandini L
    Fertil Steril; 2004 Jun; 81(6):1578-84. PubMed ID: 15193480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very long-chain fatty acids in Rett syndrome.
    Stradomska TJ; Tylki-Szymańska A; Bentkowski Z
    Eur J Pediatr; 1999 Mar; 158(3):226-9. PubMed ID: 10094444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind trial of bromocriptine in the Rett syndrome.
    Zappella M
    Brain Dev; 1990; 12(1):148-50. PubMed ID: 2344010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
    Benvenga S; Ruggeri RM; Russo A; Lapa D; Campenni A; Trimarchi F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3579-94. PubMed ID: 11502782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
    Glaze DG; Neul JL; Kaufmann WE; Berry-Kravis E; Condon S; Stoms G; Oosterholt S; Della Pasqua O; Glass L; Jones NE; Percy AK;
    Neurology; 2019 Apr; 92(16):e1912-e1925. PubMed ID: 30918097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.
    Cruciani RA; Dvorkin E; Homel P; Culliney B; Malamud S; Lapin J; Portenoy RK; Esteban-Cruciani N
    J Pain Symptom Manage; 2009 Apr; 37(4):622-31. PubMed ID: 18809275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carnitine deficiency and carnitine therapy in a patient with Rett syndrome].
    Plöchl E; Sperl W; Wermuth B; Colombo JP
    Klin Padiatr; 1996; 208(3):129-34. PubMed ID: 8676601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.